Related Experiment Video
Updated: Jul 5, 2026

Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner
Seiko Oda1, Tomoyuki Oda, Kenichiro Nishi
1Department of Anesthesia, Kyoto University Hospital, Kyoto University, Kyoto, Japan.
Background:
Macrophage migration inhibitory factor (MIF) is not only a cytokine which has a critical role in several inflammatory conditions but also has endocrine and enzymatic functions. MIF is identified as an intracellular signaling molecule and is implicated in the process of tumor progression, and also strongly enhances neovascularization. Overexpression of MIF has been observed in tumors from various organs. MIF is one of the genes induced by hypoxia in an hypoxia-inducible factor 1 (HIF-1)-dependent manner.
Methods/Principal Findings:
The effect of MIF on HIF-1 activity was investigated in human breast cancer MCF-7 and MDA-MB-231 cells, and osteosarcoma Saos-2 cells. We demonstrate that intracellular overexpression or extracellular administration of MIF enhances activation of HIF-1 under hypoxic conditions in MCF-7 cells. Mutagenesis analysis of MIF and knockdown of 53 demonstrates that the activation is not dependent on redox activity of MIF but on wild-type p53. We also indicate that the MIF receptor CD74 is involved in HIF-1 activation by MIF at least when MIF is administrated extracellularly.
Conclusion/Significance:
MIF regulates HIF-1 activity in a p53-dependent manner. In addition to MIF's potent effects on the immune system, MIF is linked to fundamental processes conferring cell proliferation, cell survival, angiogenesis, and tumor invasiveness. This functional interdependence between MIF and HIF-1alpha protein stabilization and transactivation activity provide a molecular mechanism for promotion of tumorigenesis by MIF.
Insights
Macrophage migration inhibitory factor (MIF) regulates hypoxia-inducible factor 1 (HIF-1) activity via a p53-dependent mechanism. This finding reveals a molecular pathway through which MIF promotes tumor progression and invasiveness.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Macrophage migration inhibitory factor (MIF) is a cytokine involved in inflammation, tumor progression, and neovascularization.
- MIF is induced by hypoxia in a hypoxia-inducible factor 1 (HIF-1)-dependent manner.
- Overexpression of MIF is observed in various human tumors.
Purpose of the Study:
- To investigate the effect of MIF on HIF-1 activity in human cancer cells.
- To elucidate the molecular mechanisms underlying MIF-mediated HIF-1 activation.
Main Methods:
- Experiments were conducted using human breast cancer cell lines (MCF-7, MDA-MB-231) and osteosarcoma cells (Saos-2).
- Intracellular MIF overexpression and extracellular MIF administration were employed.
- Mutagenesis analysis of MIF and p53 knockdown were performed.
- The role of the MIF receptor CD74 was assessed.
Main Results:
- Intracellular MIF overexpression and extracellular MIF administration enhanced HIF-1 activation under hypoxia in MCF-7 cells.
- MIF-mediated HIF-1 activation was dependent on wild-type p53, not MIF's redox activity.
- The MIF receptor CD74 was implicated in extracellular MIF-induced HIF-1 activation.
Conclusions:
- MIF regulates HIF-1 activity through a p53-dependent pathway.
- This functional link between MIF and HIF-1 provides a molecular mechanism for MIF's role in promoting tumorigenesis.
- MIF's involvement in cell proliferation, survival, angiogenesis, and tumor invasiveness is further supported.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway

